| An early-biomarker algorithm predicts lethal graft-versus-host disease and survival MJ Hartwell, U Özbek, E Holler, AS Renteria, H Major-Monfried, P Reddy, ... JCI insight 2 (3), 2017 | 241 | 2017 |
| MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD H Major-Monfried, AS Renteria, A Pawarode, P Reddy, F Ayuk, E Holler, ... Blood, The Journal of the American Society of Hematology 131 (25), 2846-2855, 2018 | 194 | 2018 |
| Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma K Wudhikarn, ML Palomba, M Pennisi, M Garcia-Recio, JR Flynn, ... Blood cancer journal 10 (8), 79, 2020 | 177 | 2020 |
| Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management M Pennisi, T Jain, BD Santomasso, E Mead, K Wudhikarn, ML Silverberg, ... Blood advances 4 (4), 676-686, 2020 | 123 | 2020 |
| DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality K Wudhikarn, M Pennisi, M Garcia-Recio, JR Flynn, A Afuye, ... Blood advances 4 (13), 3024-3033, 2020 | 101 | 2020 |
| Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma C Polprasert, Y Takeuchi, N Kakiuchi, K Yoshida, T Assanasen, W Sitthi, ... Blood advances 3 (4), 588-595, 2019 | 87 | 2019 |
| The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease HK Srinagesh, U Özbek, U Kapoor, F Ayuk, M Aziz, K Ben-David, ... Blood advances 3 (23), 4034-4042, 2019 | 86 | 2019 |
| Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy K Wudhikarn, JR Flynn, I Rivière, M Gönen, X Wang, B Senechal, ... Blood, The Journal of the American Society of Hematology 138 (7), 531-543, 2021 | 59 | 2021 |
| Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy K Wudhikarn, MA Perales Bone marrow transplantation 57 (10), 1477-1488, 2022 | 53 | 2022 |
| Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome K Wudhikarn, CG Brunstein, V Bachanova, LJ Burns, Q Cao, DJ Weisdorf Biology of Blood and Marrow Transplantation 17 (10), 1497-1504, 2011 | 49 | 2011 |
| Post‐transplant lymphoproliferative disorders in lung transplant recipients: 20‐yr experience at the University of Minnesota K Wudhikarn, CJ Holman, M Linan, AH Blaes, JM Dunitz, ME Hertz, ... Clinical transplantation 25 (5), 705-713, 2011 | 45 | 2011 |
| Non‐Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand T Intragumtornchai, U Bunworasate, K Wudhikarn, A Lekhakula, ... Hematological oncology 36 (1), 28-36, 2018 | 43 | 2018 |
| Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action K Wudhikarn, B Wills, AM Lesokhin Best Practice & Research Clinical Haematology 33 (1), 101143, 2020 | 39 | 2020 |
| The International Prognostic Index is associated with outcomes in diffuse large B cell lymphoma after chimeric antigen receptor T cell therapy M Garcia-Recio, K Wudhikarn, M Pennisi, R Alonso-Trillo, J Flynn, ... Transplantation and cellular therapy 27 (3), 233-240, 2021 | 35 | 2021 |
| Future of CAR T cells in multiple myeloma K Wudhikarn, S Mailankody, EL Smith Hematology 2014, the American Society of Hematology Education Program Book …, 2020 | 29 | 2020 |
| Novel DDX41 variants in Thai patients with myeloid neoplasms C Polprasert, J Takeda, P Niparuck, T Rattanathammethee, A Pirunsarn, ... International Journal of Hematology 111, 241-246, 2020 | 29 | 2020 |
| Adrenal extranodal NK/T‐cell lymphoma diagnosed by fine‐needle aspiration and cerebrospinal fluid cytology and immunophenotyping: A case report KK Dunning, K Wudhikarn, AO Safo, CJ Holman, RW McKenna, ... Diagnostic Cytopathology 37 (9), 686-695, 2009 | 28 | 2009 |
| Programmed cell death 1 and programmed cell death ligands in extranodal natural killer/T cell lymphoma: expression pattern and potential prognostic relevance H Muhamad, N Suksawai, T Assanasen, C Polprasert, U Bunworasate, ... Acta Haematologica 143 (1), 78-88, 2020 | 26 | 2020 |
| Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy K Wudhikarn, AA Tomas, JR Flynn, SM Devlin, J Brower, V Bachanova, ... Blood Advances 7 (13), 3192-3198, 2023 | 24 | 2023 |
| Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes ES Martin, A Ferrer, AA Mangaonkar, SP Khan, MA Kohorst, AY Joshi, ... American journal of hematology 96 (11), 1450-1460, 2021 | 24 | 2021 |
